Skip to content

Medical-device intelligence

Randox Laboratories Ltd.: FDA clearances and recalls

Research Randox Laboratories Ltd. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

115 clearance records and 79 recall records in the covered releases, across 1 source company names and 82 product codes. Dated history runs from Oct 15, 1992 to Jun 7, 2024.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

194 matching records
Device / recordCompany in FDA recordSourceSource date
Randox Liquid Assayed Specific Protein Control - Level 2 (SP Control 2), Cat. no. PS2683Z-2279-2018 · JJYRandox Laboratories Ltd.RecallJun 13, 2018FDA classification date
Randox Liquid Assayed Specific Protein Control - Level 3 (SP Control 3), Cat. no. PS2684Z-2280-2018 · JJYRandox Laboratories Ltd.RecallJun 13, 2018FDA classification date
Lipase, Catalog number: LI3837; GTIN: 05055273204230 and Catalog number: LI8361; GTIN: 05055273214284 Product Usage: For Professional Use for th…Z-1631-2018 · CDTRandox Laboratories Ltd.RecallMay 4, 2018FDA record creation date
Rx series HbA1c REF/Catalog Number HA3830, GTIN 05055273203561, IVD; -- RANDOX LABORATORIES LTD. , This product is suitable for use on RX series…Z-0285-2018 · LCPRandox Laboratories Ltd.RecallDec 22, 2017FDA record creation date
Randox RX Daytona Plus Magnesium (MG)K162200 · JGJRandox Laboratories, Ltd.510(k)Apr 28, 2017FDA decision date
Randox Lipase (Colorimetric) Product Usage: A lipase test system is a device intended to measure the activity of the enzyme lipase in serum and …Z-0123-2017 · CDTRandox Laboratories Ltd.RecallOct 18, 2016FDA classification date
IgE Calibrator SeriesZ-0050-2017 · DGCRandox Laboratories Ltd.RecallOct 6, 2016FDA classification date
Liquid CO2-2 (LCO2-2)K152085 · KHSRandox Laboratories, Ltd.510(k)Feb 24, 2016FDA decision date
Direct HDL Cholesterol (HDL)K153435 · LBSRandox Laboratories, Ltd.510(k)Jan 8, 2016FDA decision date
CholesterolK150654 · CHHRandox Laboratories, Ltd.510(k)Sep 29, 2015FDA decision date
RX DAYTONA PLUS CHEMISTRY ANALYZER; RX DAYTONA PLUS ASPARTATE AMINOTRANSFERASE (AST) REAGENTK131554 · JJERandox Laboratories, Ltd.510(k)Jan 9, 2014FDA decision date
RANDOX LIQUID CK-MB, RANDOX CK-MB CALIBRATORK123977 · CGSRandox Laboratories, Ltd.510(k)Nov 21, 2013FDA decision date
RANDOX CSF CONTROLS LEVELS 2 AND 3K132156 · JJYRandox Laboratories, Ltd.510(k)Oct 23, 2013FDA decision date
BENZODIAZEPINE CALIBRATOR SET, BENZODIAZEPINE CONTROL LEVEL 1, AND BENZODIAZEPINE CONTROL LEVEL 2K132090 · DLJRandox Laboratories, Ltd.510(k)Aug 8, 2013FDA decision date
HBA1C CONTROL, LEVEL 1 AND LEVEL 2K131999 · JJXRandox Laboratories, Ltd.510(k)Jul 26, 2013FDA decision date
ALDOLASE CONTROLS LEVEL 2, AND ALDOLASE CONTROL LEVEL 3K131776 · JJXRandox Laboratories, Ltd.510(k)Jul 18, 2013FDA decision date
RANDOX IMMUNOASSAY SPECIALITY CONTROL (II), LEVEL 1, LEVEL 2 AND LEVEL 3K121603 · JJYRandox Laboratories, Ltd.510(k)Nov 20, 2012FDA decision date
RANDOX MATERNAL CONTROL, LEVELS 1, 2 AND 3K113720 · JJYRandox Laboratories, Ltd.510(k)Sep 20, 2012FDA decision date
RANDOX MICROALBUMIN CONTROL LEVEL 1 AND CONTROL LEVEL 2 (LIQUID)K121746 · JJXRandox Laboratories, Ltd.510(k)Jul 11, 2012FDA decision date
RANDOX CYSTATIN C CONTROL LEVEL 2 RANDOX CYSTATIN C CONTROL LEVEL 3K121588 · JJXRandox Laboratories, Ltd.510(k)Jun 20, 2012FDA decision date
RANDOX COCAINE METABOLITEK113751 · DIORandox Laboratories, Ltd.510(k)May 8, 2012FDA decision date
RANDOX LIQUID IMMUNOASSAY PREMIUM CONTROLS, LEVEL 1, LEVEL2, LEVEL 3 AND TRI LEVELK112337 · JJYRandox Laboratories, Ltd.510(k)Dec 1, 2011FDA decision date
RANDOX DIGOXIN ASSAYK102346 · KXTRandox Laboratories, Ltd.510(k)Oct 14, 2011FDA decision date
RANDOX LIQUID URINE CONTROL LEVELS 2 AND 3K110904 · JJYRandox Laboratories, Ltd.510(k)Sep 30, 2011FDA decision date
RANDOX BARITURATES ASSAYK092268 · DISRandox Laboratories, Ltd.510(k)May 25, 2011FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗